Skip to content

An Integrative Approach for Idiopathic Granulomatous Mastitis.

Traditional and Complementary Medicine: a Cure for Idiopathic Granulomatous Mastitis?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04096300
Acronym
IIGM
Enrollment
30
Registered
2019-09-19
Start date
2019-06-01
Completion date
2019-09-30
Last updated
2019-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Granulomatous Mastitis

Keywords

Integrative Medicine, Ethnomedicine, Hirudotherapy, Idiopathic Granulomatous Mastitis, Medical Cupping Therapy, Traditional and Complementary Medicine

Brief summary

Collaboration is established between Turkish Holistic & Integrative Medicine Association and Traditional & Complementary Medicine Society of Istanbul Medipol University. Study is carried out on idiopathic granulomatous mastitis patients who are followed in the Breast Clinic at Istanbul Medipol University Hospital for between September 2015 and September 2019. Hirudotherapy and medical cupping therapy were applied as traditional and complementary medicine integratively. Following initial radiological imaging, microbiological- and histological testing, side effects and relapses are analyzed. Follow-up examination is also carried out at the end of the treatment, which consisted of clinical breast exam and radiological imaging.

Interventions

None listed

Sponsors

Medipol University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years

Inclusion criteria

* IGM patients, either ones newly diagnosed or had previously received different types of treatments, currently refusing conventional treatments with immunosuppressives etc, or/and surgical management, and now und

Exclusion criteria

* Patients currently using any conventional treatment, and/or contraindication to hirudotherapy and cupping.

Design outcomes

Primary

MeasureTime frameDescription
Change of Breast Mass SizeUp to 12 monthsUltrasonic scan at 6 months

Secondary

MeasureTime frameDescription
Change of Breast Mass SizeUp to 48 monthsMRI scan at 12 months, if prompted by ultrasonic scan

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026